JRSIS Health Care Corporation (JRSS) Stock
Established in 2006, JRSIS Health Care Corporation, originally named China Runteng Medical Group Co., Ltd until its rebranding in November 2013, operates from Harbin in China's Heilongjiang Province. The corporation specializes in delivering a broad spectrum of medical services.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About JRSIS Health Care Corporation
Established in 2006, JRSIS Health Care Corporation, originally named China Runteng Medical Group Co., Ltd until its rebranding in November 2013, operates from Harbin in China's Heilongjiang Province. The corporation specializes in delivering a broad spectrum of medical services. These include pediatrics, dermatology, otolaryngology (ears, nose, and throat), traditional Chinese medicine, ophthalmology, internal medicine, dentistry, general surgery, rehabilitation sciences, and gynecology, alongside various general healthcare provisions. JRSIS facilitates these services primarily through Jiarun Hospital, a substantial medical facility equipped with 950 patient beds.
JRSIS Health Care Corporation is headquartered in CN.
JRSIS Health Care Corporation (JRSS) stock trades at $0.02 with a market capitalization of $1.52M. The stock is valued at a price-to-earnings (P/E) ratio of -9.47, price-to-book of -7.89, price-to-sales of 6.44. Over the past 52 weeks the stock has ranged between $0.01 and $0.20, and currently trades 90.0% below its 52-week high.
On profitability, JRSIS Health Care Corporation generates a return on equity (ROE) of 6.47%, return on capital employed of 5.72%, an operating margin of -5.36%, a net profit margin of -5.11%.
Official website: www.jhcc.cn